3.5. Elafibranor-Mediated Induction of ANGPTL4, PDK4, and PLIN2 In Vitro Predicts Induction of Steatosis, Contrarily to Anti-NASH Bariatric Surgery. Here, ANGPTL4 is linked to metabolic dysfunction-associated steatohepatitis.